Skip to main content
. 2023 May 8;11(3):e00569-23. doi: 10.1128/spectrum.00569-23

TABLE 2.

The frequency of inoculum effect among susceptible carbapenemase-producing Enterobacteriaceae isolatesa,b

Antimicrobial Agent Total % (n/n) Metallo-β-Lactamase, % (n/n)
KPC, % (n/n) OXA-48-like, % (n/n) P-value
All MBL NDM IMP VIM MBL vs. KPC vs. OXA-48-like MBL vs. KPC MBL vs. OXA-48-like
Cefiderocol 95.9 (164/171) 98.4 (121/123) 100 (58/58) 94.5 (37/39) 100 (26/26) 88.6 (31/35) 92.3 (12/13) 0.027 0.022 0.262
E. coli (n = 49) 93.9 (46/49) 94.6 (35/37) 100 (16/16) 88.2 (15/17) 100 (4/4) 100 (7/7) 80.0 (4/5)
ECC (n = 34) 100 (34/34) 100 (34/34) 100 (24/24) 100 (10/10) NA NA NA
K. pneumoniae (n = 74) 94.6 (70/74) 100 (38/38) 100 (13/13) 100 (5/5) 100 (20/20) 85.7 (24/28) 100 (8/8)
Aztreonam-avibactam 95.2 (180/189) 94.2 (129/137) 94.2 (65/69) 92.9 (39/42) 96.2 (25/26) 97.4 (37/38) 100 (14/14) 0.845 0.686 >0.999
E. coli (n = 50) 82.0 (41/50) 78.4 (29/37) 76.5 (13/17) 82.4 (14/17) 66.7 (2/3) 87.5 (7/8) 100 (5/5)
ECC (n = 44) 100 (44/44) 100 (44/44) 100 (31/31) 100 (13/13) NA NA NA
K. pneumoniae (n = 79) 100 (79/79) 100 (40/40) 100 (14/14) 100 (5/5) 100 (21/21) 100 (30/30) 100 (9/9)
a

The inoculum effect was investigated on CPE isolates with a cefiderocol MIC ≤ 4 mg/L or aztreonam-avibactam MIC ≤ 4/4 mg/L at standard inoculum.

b

ECC, Enterobacter cloacae complex; MBL, metallo-β-Lactamase; NA, not applicable.